1. D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial. (April 2014) Authors: Cohen, A. T.; Spiro, T.E.; Spyropoulos, A. C.; DeSanctis, Y. H.; Homering, M.; Büller, H. R.; Haskell, L.; Hu, D.; Hull, R.; Mebazaa, A.; Merli, G.; Schellong, S.; Tapson, V. F.; Burton, P. Journal: Journal of thrombosis and haemostasis Issue: Volume 12:Number 4(2014:Apr.) Page Start: 479 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of the antifactor XA chromogenic assay for measuring rivaroxaban plasma concentrations using calibrators and controls. Issue 2 (12th March 2012) Authors: Samama, M.; Contant, G.; Spiro, T.E.; Perzborn, E.; Guinet, C.; Gourmelin, Y.; Le Flem, L.; Rohde, G.; Martinoli, J.L. Journal: European journal of hospital pharmacy Issue: Volume 19:Issue 2(2012) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls. Issue 2 (12th March 2012) Authors: Samama, M.; Contant, G.; Spiro, T.E.; Perzborn, E.; Le Flem, L.; Guinet, C.; Gourmelin, Y.; Martinoli, J.L. Journal: European journal of hospital pharmacy Issue: Volume 19:Issue 2(2012) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗